Walvax Biotechnology Market Cap

Walvax Biotechnology has a market cap or net worth of 17.21 billion as of June 27, 2025. Its market cap has decreased by -19.66% in one year.

Market Cap

17.21B

Enterprise Value

16.23B

Revenue

2.68B

Ranking

n/a

PE Ratio

130.66

Stock Price

10.93

Market Cap Chart

Since November 12, 2010, Walvax Biotechnology's market cap has increased from 13.63B to 17.21B, an increase of 26.21%. That is a compound annual growth rate of 1.60%.

Market Cap History

Date	Market Cap	% Change
Jun 27, 2025	17.48B	-9.52%
Dec 31, 2024	19.32B	-48.62%
Dec 29, 2023	37.60B	-41.50%
Dec 30, 2022	64.27B	-28.12%
Dec 31, 2021	89.42B	50.25%
Dec 31, 2020	59.52B	19.33%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Jiangsu Hengrui Medicine	345.12B
Shenzhen Mindray Bio-Medical Electronics	275.14B
WuXi AppTec	189.25B
Zhangzhou Pientzehuang Pharmaceutical.,	121.15B
Sichuan Biokin Pharmaceutical	119.30B
Aier Eye Hospital Group	115.08B
Shanghai United Imaging Healthcare	105.85B
Yunnan Baiyao Group Co.,Ltd	100.51B

Market Cap Rankings